A Meta-Analysis of Obesity and Risk of Colorectal Cancer in Patients with Lynch Syndrome: The Impact of Sex and Genetics.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
20 May 2021
Historique:
received: 15 04 2021
revised: 10 05 2021
accepted: 17 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 23 7 2021
Statut: epublish

Résumé

There appears to be a sex-specific association between obesity and colorectal neoplasia in patients with Lynch Syndrome (LS). We meta-analyzed studies reporting on obesity and colorectal cancer (CRC) risk in LS patients to test whether obese subjects were at increased risk of cancer compared to those of normal weight. We explored also a possible sex-specific relationship between adiposity and CRC risk among patients with LS. The summary relative risk (SRR) and 95% confidence intervals (CI) were calculated through random effect models. We investigated the causes of between-study heterogeneity and assessed the presence of publication bias. We were able to retrieve suitable data from four independent studies. We found a twofold risk of CRC in obese men compared to nonobese men (SRR = 2.09; 95%CI: 1.23-3.55, I

Identifiants

pubmed: 34065344
pii: nu13051736
doi: 10.3390/nu13051736
pmc: PMC8160758
pii:
doi:

Substances chimiques

MLH1 protein, human 0
MutL Protein Homolog 1 EC 3.6.1.3

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Références

Public Health Genomics. 2019;22(5-6):189-207
pubmed: 31805557
Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1373-80
pubmed: 26082403
Genet Med. 2020 Jan;22(1):15-25
pubmed: 31337882
Fam Cancer. 2013 Jun;12(2):313-7
pubmed: 23568035
Eur J Cancer Prev. 2017 Jan;26(1):94-105
pubmed: 27662398
Obstet Gynecol. 2005 Mar;105(3):569-74
pubmed: 15738026
N Engl J Med. 2018 Aug 23;379(8):764-773
pubmed: 30134129
BMJ. 2019 Aug 2;366:l5010
pubmed: 31375546
JAMA. 2000 Apr 19;283(15):2008-12
pubmed: 10789670
BMJ Open. 2018 Feb 1;8(2):e019410
pubmed: 29391383
Br J Cancer. 2011 Jun 28;105(1):162-9
pubmed: 21559014
Nutr Res. 2019 Oct;70:26-31
pubmed: 30274687
Stat Med. 2002 Feb 28;21(4):589-624
pubmed: 11836738
J Med Internet Res. 2013 Aug 08;15(8):e152
pubmed: 23928492
Nat Genet. 2009 Jan;41(1):112-7
pubmed: 19098912
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
Front Oncol. 2015 Feb 02;5:19
pubmed: 25699240
Gastroenterology. 2020 Apr;158(5):1326-1333
pubmed: 31926173
J Clin Oncol. 2015 Nov 1;33(31):3591-7
pubmed: 26282643
Clin Gastroenterol Hepatol. 2007 Jun;5(6):736-42
pubmed: 17544999
Br J Surg. 2020 Mar;107(4):348-354
pubmed: 31976551
Fam Cancer. 2013 Dec;12(4):707-18
pubmed: 23880960
Cancer Epidemiol Biomarkers Prev. 2015 Jul;24(7):1024-31
pubmed: 25976416
BMJ. 2018 Jun 13;361:k2538
pubmed: 29898885
Nat Rev Gastroenterol Hepatol. 2018 Nov;15(11):651-652
pubmed: 30315311
Stat Med. 2001 Feb 28;20(4):641-54
pubmed: 11223905
Br J Cancer. 2016 Jul 12;115(2):266-72
pubmed: 27336604
Nat Rev Cancer. 2015 Mar;15(3):181-94
pubmed: 25673086
Obes Surg. 2018 Apr;28(4):945-954
pubmed: 28990150
BMJ. 2014 May 14;348:g2646
pubmed: 25134100
J Clin Oncol. 2010 Oct 1;28(28):4346-53
pubmed: 20733131
Annu Rev Pathol. 2016 May 23;11:421-49
pubmed: 27193454
J Natl Cancer Inst. 2004 Feb 18;96(4):261-8
pubmed: 14970275
Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1735-44
pubmed: 17855691
Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):404-412
pubmed: 27799157
Gastroenterology. 2004 Jan;126(1):42-8
pubmed: 14699485
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Epidemiol Rev. 1987;9:1-30
pubmed: 3678409
Cancer Res. 2013 Mar 1;73(5):1600-10
pubmed: 23442321
BMC Med. 2020 Dec 17;18(1):396
pubmed: 33327948

Auteurs

Matteo Lazzeroni (M)

Division of Cancer Prevention and Genetics, European Institute of Oncology (IEO) IRCCS, 20141 Milan, Italy.

Federica Bellerba (F)

Department of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, 20141 Milan, Italy.

Mariarosaria Calvello (M)

Division of Cancer Prevention and Genetics, European Institute of Oncology (IEO) IRCCS, 20141 Milan, Italy.

Finlay Macrae (F)

Department of Colorectal Medicine and Genetics, Royal Melbourne Hospital, Parkville, VIC 3050, Australia.

Aung Ko Win (AK)

Centre for Epidemiology and Biostatistics, University of Melbourne, Parkville, VIC 3050, Australia.
Victorian Comprehensive Cancer Centre, University of Melbourne Centre for Cancer Research, Parkville, VIC 3050, Australia.

Mark Jenkins (M)

Centre for Epidemiology and Biostatistics, University of Melbourne, Parkville, VIC 3050, Australia.
Victorian Comprehensive Cancer Centre, University of Melbourne Centre for Cancer Research, Parkville, VIC 3050, Australia.

Davide Serrano (D)

Division of Cancer Prevention and Genetics, European Institute of Oncology (IEO) IRCCS, 20141 Milan, Italy.

Monica Marabelli (M)

Division of Cancer Prevention and Genetics, European Institute of Oncology (IEO) IRCCS, 20141 Milan, Italy.

Sara Cagnacci (S)

Division of Cancer Prevention and Genetics, European Institute of Oncology (IEO) IRCCS, 20141 Milan, Italy.

Gianluca Tolva (G)

Division of Cancer Prevention and Genetics, European Institute of Oncology (IEO) IRCCS, 20141 Milan, Italy.

Debora Macis (D)

Division of Cancer Prevention and Genetics, European Institute of Oncology (IEO) IRCCS, 20141 Milan, Italy.

Sara Raimondi (S)

Department of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, 20141 Milan, Italy.

Luca Mazzarella (L)

Department of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, 20141 Milan, Italy.

Susanna Chiocca (S)

Department of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, 20141 Milan, Italy.

Saverio Caini (S)

Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), 50139 Florence, Italy.

Lucio Bertario (L)

Division of Cancer Prevention and Genetics, European Institute of Oncology (IEO) IRCCS, 20141 Milan, Italy.

Bernardo Bonanni (B)

Division of Cancer Prevention and Genetics, European Institute of Oncology (IEO) IRCCS, 20141 Milan, Italy.

Sara Gandini (S)

Department of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, 20141 Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH